Related Experiment Video
Updated: May 6, 2026
06:44
Isolation of Small Noncoding RNAs from Human Serum
Published on: June 19, 2014
18.0K
An ultrasensitive method for detection of cell-free RNA
Monica C Nesselbush1,2,3, Bogdan A Luca4, Young-Jun Jeon5
1Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Nature
|April 16, 2025
Summary
RARE-seq offers ultrasensitive detection of cell-free RNA (cfRNA), outperforming RNA sequencing and ctDNA analysis for cancer detection and monitoring. This method overcomes platelet contamination for diverse clinical applications.
Area of Science:
- Molecular Biology
- Genomics
- Biotechnology
Background:
- Sensitive detection of cell-free RNA (cfRNA) is crucial for non-invasive gene expression profiling and disease monitoring.
- Platelet contamination is a significant challenge in cfRNA analysis, potentially confounding results.
- Existing methods like whole-transcriptome RNA sequencing (RNA-seq) lack the sensitivity required for early or low-biomass disease detection.
Purpose of the Study:
- To develop and validate RARE-seq (random priming and affinity capture of cfRNA fragments for enrichment analysis by sequencing), a highly sensitive method for cfRNA analysis.
- To address and overcome the issue of platelet contamination in cfRNA samples.
- To evaluate the clinical utility of RARE-seq in diverse applications including cancer detection, resistance monitoring, and vaccine response tracking.
Main Methods:
- RARE-seq was developed, incorporating random priming and affinity capture for cfRNA enrichment.
- A novel approach was implemented to mitigate confounding effects from platelet-derived cfRNA.
- Analytical sensitivity was assessed, comparing RARE-seq to whole-transcriptome RNA sequencing.
Main Results:
- RARE-seq demonstrated approximately 50-fold higher sensitivity than RNA-seq for detecting tumor-derived cfRNA, with a limit of detection of 0.05%.
- In a clinical study of 437 plasma samples, RARE-seq detected non-small-cell lung cancer (NSCLC) expression signatures with increasing sensitivity by stage (83% in stage IV at 95% specificity), outperforming ctDNA analysis.
- RARE-seq identified resistance mechanisms in EGFR-mutant NSCLC patients and showed potential for tissue of origin determination, benign condition assessment, and mRNA vaccine response tracking.
Conclusions:
- RARE-seq is an ultrasensitive method for cfRNA analysis, significantly improving upon existing techniques.
- The method effectively overcomes platelet contamination, enhancing the reliability of cfRNA profiling.
- RARE-seq shows broad clinical potential for non-invasive disease detection, monitoring, and therapeutic response assessment.
More Related Videos
Related Concept Videos
03:21RNA-seq
9.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.4K
02:24Ribosome Profiling
3.2K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.2K